China, Sept. 8 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A multicenter, randomized, open-label, parallel-group clinical trial investigating the ... Read More
China, Sept. 8 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Research on AI Voice Medical Record Generation Algorithm Based on Multimodal Large Mode... Read More
China, Sept. 8 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Phase II Clinical Study to Evaluate the Efficacy and Safety of Hypofractionated Radio... Read More
China, Sept. 8 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Clinical observation of ethacridine lactate solution in wound management of patients af... Read More
China, Sept. 8 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Prospective Evaluation of Procedural Stability Using a Head Fixation Device in CT-Guide... Read More
China, Sept. 8 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Prospective, Single-Center, Randomized Controlled Trial Comparing Dural Puncture Epid... Read More
China, Sept. 8 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Effects of 12-Week High-Volume and Low-Volume HIIT Training on Cardiorespiratory Fitnes... Read More
China, Sept. 8 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'PET-CT/MRI-based investigation of transcranial magnetic stimulation effects on clinical... Read More
Singapore, Sept. 8 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Effect of Muvala... Read More
Singapore, Sept. 8 -- The Health Sciences Authority received information related to the study titled 'FRAmework-01: A Three-Part Phase 3 Study of Sofetabart Mipitecan (LY4170156) versus Chemotherapy o... Read More